FDG-PET Imaging in Painful Joint Prosthesis

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion dates: Feb 2026 to Feb 2027v15
  2. Notable Primary and study completion dates: Feb 2025 to Feb 2026v14
  3. Notable Primary and study completion dates: Feb 2024 to Feb 2025v13
  4. Notable Primary and study completion dates: Feb 2023 to Feb 2024v12
  5. Notable Primary and study completion dates: Feb 2022 to Feb 2023v11
Show 9 earlier versionsHide 9 earlier versions
  1. Notable Primary and study completion dates: Jan 2021 to Feb 2022v10
  2. Notable Primary and study completion dates: Jan 2020 to Jan 2021v9
  3. 2 versions Re-verified since May 3, 2018, no change to tracked fieldsv7-v8
  4. Notable Primary completion date: Jan 2017 to Jan 2020
    • Study completion date: Jan 2020
    v6
  5. Notable Primary completion date: Jan 2016 to Jan 2017v5
  6. Notable Primary completion date: Jan 2014 to Jan 2016v4
  7. Notable Phase: Phase 2/3 to Not specified
    • Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jan 2014
    • Site details revised
    v3
  8. Minor Site contact updatedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of the proposed research study is to determine the efficacy of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiating infections from other complications such as loosening in patients with painful joint prosthesis. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities such as white blood imaging and patient outcome. We expect that at the completion of the proposed research, the role of this novel and powerful imaging modality will be clearly defined in the management of patients with this challenging and serious complication.
Trial Details
NCT Number NCT00194285
Lead Sponsor University of Pennsylvania
Collaborators: National Institutes of Health (NIH)
Conditions
(from sponsor)
Painful Joint Prostheses
Enrollment 530 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov